Crosstalk between Dopamine D2 receptors and cannabinoid CB 1 receptors regulates CNR1 promoter activity via ERK1/2 signaling

Journal of Neurochemistry

Volumn 127, Issue 2, 2013, Pages 163-176

  Chiang, Yao Chang ^a,b   Lo, Yan Ni ^c   Chen, Jin Chung ^c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

5 untranslated region; cannabinoid CB1 receptor; dopamine D2 receptor; ERK1 2; gene regulation; promoter structure

Indexed keywords

CANNABINOID 1 RECEPTOR; DOPAMINE 2 RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

5' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN TISSUE; CB1R GENE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE D2 RECEPTOR GENE; ERK1 GENE; ERK2 GENE; EXON; FEMALE; GENE EXPRESSION REGULATION; GENE INTERACTION; INTRON; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION;

5′-UNTRANSLATED REGION; CANNABINOID CB1 RECEPTOR; DOPAMINE D2 RECEPTOR; ERK1/2; GENE REGULATION; PROMOTER STRUCTURE;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; CYCLOHEXANOLS; DNA; FEMALE; GENES, REPORTER; GLIOMA; MAP KINASE SIGNALING SYSTEM; MOLECULAR SEQUENCE DATA; NEOSTRIATUM; PLASMIDS; PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR CROSS-TALK; RECEPTOR, CANNABINOID, CB1; RECEPTORS, DOPAMINE D2; RNA; TRANSFECTION;

RATTUS;

EID: 84885418229     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12399     Document Type: Article

References (61)

1. Alen F., Moreno-Sanz G., Isabel de Tena A., Brooks R. D., Lopez-Jimenez A., Navarro M., and, Lopez-Moreno J. A., (2008) Pharmacological activation of CB1 and D2 receptors in rats: predominant role of CB1 in the increase of alcohol relapse. Eur. J. Neurosci. 27, 3292-3298.
2. Andersson M., Usiello A., Borgkvist A., et al,. (2005) Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons. J. Neurosci. 25, 8432-8438.
3. Barrero F. J., Ampuero I., Morales B., Vives F., and, de Dios Luna Del Castillo, J., Hoenicka, J. and Garcia Yebenes, J., (2005) Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1). Pharmacogenomics J. 5, 135-141.
4. Blume L. C., Bass C. E., Childers S. R., Dalton G. D., Roberts D. C., Richardson J. M., Xiao R., Selley D. E., and, Howlett A. C., (2013) Striatal CB1 and D2 receptors regulate expression of each other, CRIP1A and delta opioid systems. J. Neurochem. 124, 808-820.
5. Borner C., Bedini A., Hollt V., and, Kraus J., (2008) Analysis of promoter regions regulating basal and interleukin-4-inducible expression of the human CB1 receptor gene in T lymphocytes. Mol. Pharmacol. 73, 1013-1019.
6. Carriba P., Ortiz O., Patkar K., et al,. (2007) Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids. Neuropsychopharmacology 32, 2249-2259.
7. Centonze D., Battista N., Rossi S., Mercuri N. B., Finazzi-Agro A., Bernardi G., Calabresi P., and, Maccarrone M., (2004) A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission. Neuropsychopharmacology 29, 1488-1497.
8. Chen J., Nye H. E., Kelz M. B., Hiroi N., Nakabeppu Y., Hope B. T., and, Nestler E. J., (1995) Regulation of delta FosB and FosB-like proteins by electroconvulsive seizure and cocaine treatments. Mol. Pharmacol. 48, 880-889.
9. Chen J. C., Su H. J., Huang L. I., and, Hsieh M. M., (1999) Reductions in binding and functions of D2 dopamine receptors in the rat ventral striatum during amphetamine sensitization. Life Sci. 64, 343-354.
10. Chen J. C., Chen P. C., and, Chiang Y. C., (2009) Molecular mechanisms of psychostimulant addiction. Chang Gung Med. J. 32, 148-154.
11. Chen H. T., Ruan N. Y., Chen J. C., and, Lin T. Y., (2012) Dopamine D2 receptor-mediated Akt/PKB signaling: initiation by D2S receptor and role in quinpirole-induced behavioral activation. ASN Neuro 4, 371-382.
12. Chiang Y. C., and, Chen J. C., (2007) The role of the cannabinoid type 1 receptor and down-stream cAMP/DARPP-32 signal in the nucleus accumbens of methamphetamine-sensitized rats. J. Neurochem. 103, 2505-2517.
13. Chiu C. Q., Puente N., Grandes P., and, Castillo P. E., (2010) Dopaminergic modulation of endocannabinoid-mediated plasticity at GABAergic synapses in the prefrontal cortex. J. Neurosci. 30, 7236-7248.
14. Galve-Roperh I., Sanchez C., Cortes M. L., Gomez del Pulgar T., Izquierdo M., and, Guzman M., (2000) Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat. Med. 6, 313-319.
15. Galve-Roperh I., Rueda D., Gomez del Pulgar T., Velasco G., and, Guzman M., (2002) Mechanism of extracellular signal-regulated kinase activation by the CB(1) cannabinoid receptor. Mol. Pharmacol. 62, 1385-1392.
16. Girault J. A., Valjent E., Caboche J., and, Herve D., (2007) ERK2: a logical AND gate critical for drug-induced plasticity? Curr. Opin. Pharmacol. 7, 77-85.
17. Giuffrida A., Parsons L. H., Kerr T. M., Rodriguez de Fonseca F., Navarro M., and, Piomelli D., (1999) Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat. Neurosci. 2, 358-363.
18. Glass M., and, Felder C. C., (1997) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J. Neurosci. 17, 5327-5333.
19. Glass M., van Dellen A., Blakemore C., Hannan A. J., and, Faull R. L., (2004) Delayed onset of Huntington's disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors. Neuroscience 123, 207-212.
20. Grobben B., De Deyn P. P., and, Slegers H., (2002) Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell Tissue Res. 310, 257-270.
21. Herkenham M., Lynn A. B., Little M. D., Johnson M. R., Melvin L. S., de Costa B. R., and, Rice K. C., (1990) Cannabinoid receptor localization in brain. Proc. Natl Acad. Sci. USA 87, 1932-1936.
22. Herkenham M., Lynn A. B., Johnson M. R., Melvin L. S., de Costa B. R., and, Rice K. C., (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11, 563-583.
23. Hermann H., Marsicano G., and, Lutz B., (2002) Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. Neuroscience 109, 451-460.
24. Howlett A. C., Blume L. C., and, Dalton G. D., (2010) CB(1) cannabinoid receptors and their associated proteins. Curr. Med. Chem. 17, 1382-1393.
25. Hwang C. K., D'Souza U. M., Eisch A. J., et al,. (2001) Dopamine receptor regulating factor, DRRF: a zinc finger transcription factor. Proc. Natl Acad. Sci. USA 98, 7558-7563.
26. Jarrahian A., Watts V. J., and, Barker E. L., (2004) D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor. J. Pharmacol. Exp. Ther. 308, 880-886.
27. Kearn C. S., Blake-Palmer K., Daniel E., Mackie K., and, Glass M., (2005) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? Mol. Pharmacol. 67, 1697-1704.
28. Kim S. J., Kim M. Y., Lee E. J., Ahn Y. S., and, Baik J. H., (2004) Distinct regulation of internalization and mitogen-activated protein kinase activation by two isoforms of the dopamine D2 receptor. Mol. Endocrinol. 18, 640-652.
29. Kofalvi A., Rodrigues R. J., Ledent C., Mackie K., Vizi E. S., Cunha R. A., and, Sperlagh B., (2005) Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis. J. Neurosci. 25, 2874-2884.
30. Lania L., Majello B., and, De Luca P., (1997) Transcriptional regulation by the Sp family proteins. Int. J. Biochem. Cell Biol. 29, 1313-1323.
31. Laprairie R. B., Kelly M. E., and, Denovan-Wright E. M., (2012) The dynamic nature of type 1 cannabinoid receptor (CB(1)) gene transcription. Br. J. Pharmacol. 167, 1583-1595.
32. Lee Y. W., Son K. W., Flora G., Hennig B., Nath A., and, Toborek M., (2002) Methamphetamine activates DNA binding of specific redox-responsive transcription factors in mouse brain. J. Neurosci. Res. 70, 82-89.
33. Lee B., London E. D., Poldrack R. A., et al,. (2009) Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J. Neurosci. 29, 14734-14740.
34. Liu H. C., Shen J. T., Augustin L. B., Ko J. L., and, Loh H. H., (1999) Transcriptional regulation of mouse delta-opioid receptor gene. J. Biol. Chem. 274, 23617-23626.
35. Luo Y., Kokkonen G. C., Wang X., Neve K. A., and, Roth G. S., (1998) D2 dopamine receptors stimulate mitogenesis through pertussis toxin-sensitive G proteins and Ras-involved ERK and SAP/JNK pathways in rat C6-D2L glioma cells. J. Neurochem. 71, 980-990.
36. Maccarrone M., Battista N., and, Centonze D., (2007) The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases. Prog. Neurobiol. 81, 349-379.
37. Maccarrone M., Rossi S., Bari M., et al,. (2008) Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nat. Neurosci. 11, 152-159.
38. Marcellino D., Carriba P., Filip M., et al,. (2008) Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis. Neuropharmacology 54, 815-823.
39. McCaw E. A., Hu H., Gomez G. T., Hebb A. L., Kelly M. E., and, Denovan-Wright E. M., (2004) Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice. Eur. J. Biochem. 271, 4909-4920.
40. McGinty J. F., Shi X. D., Schwendt M., Saylor A., and, Toda S., (2008) Regulation of psychostimulant-induced signaling and gene expression in the striatum. J. Neurochem. 104, 1440-1449.
41. Meschler J. P., and, Howlett A. C., (2001) Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum. Neuropharmacology 40, 918-926.
42. Miller L. K., and, Devi L. A., (2011) The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications. Pharmacol. Rev. 63, 461-470.
43. Mukhopadhyay S., McIntosh H. H., Houston D. B., and, Howlett A. C., (2000) The CB(1) cannabinoid receptor juxtamembrane C-terminal peptide confers activation to specific G proteins in brain. Mol. Pharmacol. 57, 162-170.
44. Navarro G., Carriba P., Gandia J., et al,. (2008) Detection of heteromers formed by cannabinoid CB1, dopamine D2, and adenosine A2A G-protein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer. ScientificWorldJournal 8, 1088-1097.
45. Onaivi E. S., Leonard C. M., Ishiguro H., Zhang P. W., Lin Z., Akinshola B. E., and, Uhl G. R., (2002) Endocannabinoids and cannabinoid receptor genetics. Prog. Neurobiol. 66, 307-344.
46. Pan B., Hillard C. J., and, Liu Q. S., (2008) D2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling. J. Neurosci. 28, 14018-14030.
47. Pickel V. M., Chan J., Kearn C. S., and, Mackie K., (2006) Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens. J. Comp. Neurol. 495, 299-313.
48. Przybyla J. A., and, Watts V. J., (2010) Ligand-induced regulation and localization of cannabinoid CB1 and dopamine D2L receptor heterodimers. J. Pharmacol. Exp. Ther. 332, 710-719.
49. Rezayof A., Habibi P., and, Zarrindast M. R., (2011) Involvement of dopaminergic and glutamatergic systems of the basolateral amygdala in amnesia induced by the stimulation of dorsal hippocampal cannabinoid receptors. Neuroscience, 175, 118-126.
50. Rinaldi-Carmona M., Barth F., Congy C., et al,. (2004) SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl) -1H-pyrazole-3 -carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterization. J. Pharmacol. Exp. Ther. 310, 905-914.
51. Robbe D., Alonso G., Duchamp F., Bockaert J., and, Manzoni O. J., (2001) Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J. Neurosci. 21, 109-116.
52. Rylski M., Amborska R., Zybura K., Konopacki F. A., Wilczynski G. M., and, Kaczmarek L., (2008) Yin Yang 1 Expression in the Adult Rodent Brain. Neurochem. Res. 12, 2556-2564.
53. Shi Y., Lee J. S., and, Galvin K. M., (1997) Everything you have ever wanted to know about Yin Yang 1. Biochim. Biophys. Acta 1332, F49-F66.
54. Usiello A., Baik J. H., Rouge-Pont F., Picetti R., Dierich A., LeMeur M., Piazza P. V., and, Borrelli E., (2000) Distinct functions of the two isoforms of dopamine D2 receptors. Nature 408, 199-203.
55. Valjent E., Pages C., Rogard M., Besson M. J., Maldonado R., and, Caboche J., (2001) Delta 9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission. Eur. J. Neurosci. 14, 342-352.
56. Valjent E., Pascoli V., Svenningsson P., et al,. (2005) Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc. Natl Acad. Sci. USA 102, 491-496.
57. Vantaggiato C., Formentini I., Bondanza A., Bonini C., Naldini L., and, Brambilla R., (2006) ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially. J. Biol. 5, 14.
58. Yao L., Fan P., Jiang Z., Mailliard W. S., Gordon A. S., and, Diamond I., (2003) Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-beta gamma dimers. Proc. Natl Acad. Sci. USA 100, 14379-14384.
59. Yao L., McFarland K., Fan P., Jiang Z., Ueda T., and, Diamond I., (2006) Adenosine A2a blockade prevents synergy between mu-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted rats. Proc. Natl Acad. Sci. USA 103, 7877-7882.
60. Zarrindast M. R., Mahboobi S., Sadat-Shirazi M. S., and, Ahmadi S., (2011) Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1 and D2 dopaminergic systems. J. Psychopharmacol. 25, 131-140.
61. Zhang P. W., Ishiguro H., Ohtsuki T., Hess J., Carillo F., Walther D., Onaivi E. S., Arinami T., and, Uhl G. R., (2004) Human cannabinoid receptor 1: 5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse. Mol. Psychiatry 9, 916-931.